Dan Zabrowski will head Roche's new sequencing unit as part of a reorganization by the company that is dissolving its Applied Science unit of the Diagnostic division (see IS 4/23/2012). Zabrowski was previously the head of Roche Applied Science. Also, as part of the reorganization, Thomas Schinecker will become general manager of Roche Diagnostics Germany in June. Previously, he was president of Roche Sequencing Solutions.
Illumina has named Charles Dadswell senior vice president and general counsel, replacing Christian Cabou, who has retired. Dadswell will be responsible for all legal and intellectual property matters and will also serve as secretary to Illumina's board of directors. He joins Illumina from BioMérieux, where he served as vice president and general counsel for North and Latin America and corporate director of global intellectual property. Previously, he was general counsel at BioDelivery Sciences International, a specialty pharmaceutical company. He holds an LLM in patent law and trade regulation from George Washington University Law School, a JD from the Thomas M. Cooley Law School, and a BS from Ferris State University.